Treatment algorithm for immune effector cell associated hematotoxicity. *Consider dexamethasone-pulse (20  mg over 4 days) or anticytokine-therapy (e.g., anakinra or tocilizumab). **Consider eltrombopag (e.g., 50  mg × 7 days). ***If available, contact apheresis unit.